Oct 23, 2018
CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited
Oct 02, 2018
CASI Pharmaceuticals Announces Appointment Of President To Its China Operations To Lead Commercialization
Sep 14, 2018
CASI Pharmaceuticals Announces $48.5 Million Private Placement
Aug 14, 2018
CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
Jul 03, 2018
CASI Pharmaceuticals Added To Russell 2000®, 3000® And Microcap® Indexes
Jun 21, 2018
CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol
May 29, 2018
CASI Pharmaceuticals To Present At The BIO International Convention
May 15, 2018
CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results
Apr 05, 2018
CASI Pharmaceuticals Provides Update On EVOMELA®
Feb 09, 2018
CASI Pharmaceuticals to Present at the BIO CEO & Investor Conference
Jan 26, 2018
CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)
Dec 01, 2017
CASI Pharmaceuticals Announces Poster Presentation At The 2017 San Antonio Breast Cancer SymposiumTM (SABCS) On ENMD-2076 In Patients With Triple-Negative Breast Cancer (TNBC)
Nov 14, 2017
CASI Pharmaceuticals Reports Third Quarter 2017 Financial Results
Oct 13, 2017
CASI Pharmaceuticals Announces $23.8 Million Registered Direct Offering Led By Existing Shareholders
Sep 07, 2017
CASI Provides Pipeline Development Update
Sep 06, 2017
CASI Pharmaceuticals To Present At The Annual Rodman & Renshaw Global Investment Conference
Aug 14, 2017
CASI Pharmaceuticals Reports Second Quarter 2017 Financial Results
May 30, 2017
CASI Pharmaceuticals Announces Poster Presentation At ASCO On ENMD-2076 In Patients With Clear Cell Ovarian Carcinoma (CCOC)